Velarion Records
Free. Unsubscribe any time.

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. filed 9 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 18 transactions and 55,000 shares. None carries the SEC's AFF10B5ONE flag; all 9 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Janux Therapeutics, Inc. 18

Adoption dates in Janux Therapeutics, Inc. 2

Results prints in Janux Therapeutics, Inc. 0

Trades before a print in Janux Therapeutics, Inc. 0

Interval to Janux Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Janux Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 30, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.